Bivalirudin in Acute Myocardial Infarction: “Primum Non Nocere”
2010; Elsevier BV; Volume: 3; Issue: 8 Linguagem: Inglês
10.1016/j.jcin.2010.07.006
ISSN1936-8798
AutoresFernándo Alfonso, Manuel Paulo,
Tópico(s)Heparin-Induced Thrombocytopenia and Thrombosis
ResumoPrimary angioplasty has been enthroned as the cornerstone of therapy in patients with ST-segment elevation myocardial infarction (STEMI) ([1–3][1]). In this scenario, coronary stenting is systematically offered. While drug-eluting stents (DES) are becoming increasingly used in STEMI patients
Referência(s)